BioTime, Inc. Share Price Nyse
Equities
US09066L1052
Biotechnology & Medical Research
Sales 2024 * | 17.54M 1.46B | Sales 2025 * | 14.63M 1.22B | Capitalization | 213M 17.8B |
---|---|---|---|---|---|
Net income 2024 * | -21M -1.75B | Net income 2025 * | -25M -2.09B | EV / Sales 2024 * | 12.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 14.6 x |
P/E ratio 2024 * |
-9.97
x | P/E ratio 2025 * |
-9.11
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.57% |
Latest transcript on BioTime, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 52 | 17/18/17 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 14/22/14 |
Chief Operating Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 01/09/01 |
Brian Culley
CEO | Chief Executive Officer | 52 | 17/18/17 |
Director/Board Member | 66 | 11/14/11 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+46.11% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |